Publications by authors named "Lynette Sholl"

100Publications

Expanding the utility of cytology preparations in cancer biomarker testing.

Cancer Cytopathol 2020 Oct 29. Epub 2020 Oct 29.

Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncy.22380DOI Listing
October 2020

Strategies for the successful implementation of plasma-based NSCLC genotyping in clinical practice.

Nat Rev Clin Oncol 2020 Sep 11. Epub 2020 Sep 11.

UC Davis Comprehensive Cancer Center, Sacramento, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41571-020-0423-xDOI Listing
September 2020

Intestinal metaplasia of the urinary tract harbors potentially oncogenic genetic variants.

Mod Pathol 2020 Aug 28. Epub 2020 Aug 28.

Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41379-020-00655-zDOI Listing
August 2020

Superior Vena Cava Syndrome associated with recurrent uterine adenosarcoma.

Gynecol Oncol Rep 2020 Aug 22;33:100613. Epub 2020 Jul 22.

Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.gore.2020.100613DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393396PMC
August 2020

Traditional Diagnostics versus Disruptive Technology: The Role of the Pathologist in the Era of Liquid Biopsy.

Cancer Res 2020 Aug 30;80(16):3197-3199. Epub 2020 Jun 30.

Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-20-0134DOI Listing
August 2020

Poly (ADP Ribose) Polymerase Inhibitors for Cancer: Essential Biologic, Diagnostic, and Therapeutic Concepts for Today's Practitioner.

J Mol Diagn 2020 Sep 20;22(9):1126-1128. Epub 2020 Jun 20.

PARP Inhibitor (PARPi) Series Content Committee of the Training and Education Committee, Association for Molecular Pathology, Rockville, Maryland; Department of Clinical Laboratory Genetics, University Heath Network, Toronto, Ontario, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmoldx.2020.06.002DOI Listing
September 2020

ARID1A mutations and expression loss in non-small cell lung carcinomas: clinicopathologic and molecular analysis.

Mod Pathol 2020 11 22;33(11):2256-2268. Epub 2020 Jun 22.

Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41379-020-0592-2DOI Listing
November 2020

In situ detection of SARS-CoV-2 in lungs and airways of patients with COVID-19.

Mod Pathol 2020 11 19;33(11):2104-2114. Epub 2020 Jun 19.

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41379-020-0595-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7304376PMC
November 2020

Malignant tumours of the uterus and ovaries with Mullerian and germ cell or trophoblastic components have a somatic origin and are characterised by genomic instability.

Histopathology 2020 Nov 22;77(5):788-797. Epub 2020 Sep 22.

Women's and Perinatal Pathology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.14188DOI Listing
November 2020

Molecular Diagnostics in Non-Small Cell Lung Carcinoma.

Authors:
Lynette M Sholl

Semin Respir Crit Care Med 2020 Jun 25;41(3):386-399. Epub 2020 May 25.

Department of Pathology, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0039-3399564DOI Listing
June 2020

Next-generation sequencing informs diagnosis and identifies unexpected therapeutic targets in lung squamous cell carcinomas.

Lung Cancer 2020 02 16;140:35-41. Epub 2019 Dec 16.

Department of Pathology, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2019.12.005DOI Listing
February 2020

Programmed death ligand 1 immunohistochemistry: can we agree on this?

Authors:
Lynette M Sholl

Histopathology 2020 01;76(2):189-190

Brigham and Women's Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13998DOI Listing
January 2020

Metaplastic thymoma: a distinctive thymic neoplasm characterized by YAP1-MAML2 gene fusions.

Mod Pathol 2020 04 22;33(4):560-565. Epub 2019 Oct 22.

Department of Pathology, Brigham and Women's Hospital, 75 Francis Street, Boston, MA, 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41379-019-0382-xDOI Listing
April 2020

Molecular Analysis of a Patient With Neurofibromatosis 2 (NF2) and Peritoneal Malignant Mesothelioma.

Am J Surg Pathol 2020 02;44(2):288-292

Department of Pathology, Duke University Medical Center, Durham, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000001359DOI Listing
February 2020

Imaging of Precision Therapy for Lung Cancer: Current State of the Art.

Radiology 2019 10 6;293(1):15-29. Epub 2019 Aug 6.

From the Departments of Imaging (H.P., M.N.) and Medical Oncology (M.M.A.), Dana-Farber Cancer Institute, and Departments of Radiology (H.P., H.H., M.N.), Pathology (L.M.S.), and Medicine (M.M.A.), Brigham and Women's Hospital, 450 Brookline Ave, Boston, MA 02215.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2019190173DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776234PMC
October 2019

Metastatic Basal Cell Carcinoma.

Am J Clin Pathol 2019 11;152(6):706-717

Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ajcp/aqz089DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829017PMC
November 2019

Sensitivity of next-generation sequencing assays detecting oncogenic fusions in plasma cell-free DNA.

Lung Cancer 2019 08 5;134:96-99. Epub 2019 Jun 5.

Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, 360 Longwood Avenue, Boston, MA, 02215, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2019.06.004DOI Listing
August 2019

MET IHC Is a Poor Screen for MET Amplification or MET Exon 14 Mutations in Lung Adenocarcinomas: Data from a Tri-Institutional Cohort of the Lung Cancer Mutation Consortium.

J Thorac Oncol 2019 09 20;14(9):1666-1671. Epub 2019 Jun 20.

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.06.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708730PMC
September 2019

Detection of ERBB2 Amplification by Next-Generation Sequencing Predicts HER2 Expression in Colorectal Carcinoma.

Am J Clin Pathol 2019 06;152(1):97-108

Department of Pathology, Brigham and Women's Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ajcp/aqz031DOI Listing
June 2019

Characteristics of mismatch repair deficiency in sarcomas.

Mod Pathol 2019 07 14;32(7):977-987. Epub 2019 Feb 14.

Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41379-019-0202-3
Publisher Site
http://dx.doi.org/10.1038/s41379-019-0202-3DOI Listing
July 2019

Identification of diverse activating mutations of the RAS-MAPK pathway in histiocytic sarcoma.

Mod Pathol 2019 06 9;32(6):830-843. Epub 2019 Jan 9.

Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/s41379-018-0200-x
Publisher Site
http://dx.doi.org/10.1038/s41379-018-0200-xDOI Listing
June 2019

Recognizing the Challenges of Oncogene Fusion Detection: A Critical Step toward Optimal Selection of Lung Cancer Patients for Targeted Therapies.

Authors:
Lynette M Sholl

J Thorac Oncol 2018 10;13(10):1433-1435

Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864183093
Publisher Site
http://dx.doi.org/10.1016/j.jtho.2018.08.002DOI Listing
October 2018

Reply to Petals and thorns in programmed death-ligand 1 testing: Is all non-small cell lung cancer diagnostic material suitable?

Cancer Cytopathol 2018 09 21;126(9):819-820. Epub 2018 Sep 21.

Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncy.22032
Publisher Site
http://dx.doi.org/10.1002/cncy.22032DOI Listing
September 2018

Diagnostic and Predictive Immunohistochemistry for Non-Small Cell Lung Carcinomas.

Adv Anat Pathol 2018 Nov;25(6):374-386

Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAP.0000000000000206DOI Listing
November 2018

Targeted Genomic Profiling of Female Adnexal Tumors of Probable Wolffian Origin (FATWO).

Int J Gynecol Pathol 2019 Nov;38(6):543-551

Department of Pathology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada (J.M.) Department of Pathology (F.D., L.M.S., E.G., N.L.) Department of Pathology, Division of Women's and Perinatal Pathology (J.M., C.P.C., M.R.N., B.E.H.), Brigham and Women's Hospital Dana-Farber Cancer Institute (E.G., L.M.), Boston, Massachusetts Department of Pathology, Belfast Health and Social Care Trust, Belfast, Northern Ireland, UK (W.G.M.) Department of Pathology, Stanford University School of Medicine, Stanford, California (B.E.H.).

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00004347-900000000-9915
Publisher Site
http://dx.doi.org/10.1097/PGP.0000000000000545DOI Listing
November 2019

Liquid biopsy of fine-needle aspiration supernatant for lung cancer genotyping.

Lung Cancer 2018 08 25;122:72-75. Epub 2018 May 25.

Lowe Center for Thoracic Oncology, Dana Farber Cancer Institute, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2018.05.024DOI Listing
August 2018

Validation of a targeted next-generation sequencing approach to detect mismatch repair deficiency in colorectal adenocarcinoma.

Mod Pathol 2018 12 28;31(12):1882-1890. Epub 2018 Jun 28.

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41379-018-0091-xDOI Listing
December 2018

Mutations and PD-1 Inhibitor Resistance in -Mutant Lung Adenocarcinoma.

Cancer Discov 2018 07 17;8(7):822-835. Epub 2018 May 17.

Department of Thoracic and Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-18-0099DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030433PMC
July 2018

Interpathologist Diagnostic Agreement for Non-Small Cell Lung Carcinomas Using Current and Recent Classifications.

Arch Pathol Lab Med 2018 12 30;142(12):1537-1548. Epub 2018 Apr 30.

From the Department of Pathology & Laboratory Medicine, University of North Carolina School of Medicine, Chapel Hill (Drs Funkhouser Jr and Banks); Lineberger Comprehensive Cancer Center, UNC, Chapel Hill, North Carolina (Drs Funkhouser Jr, Hayes, Nikolaishvilli-Feinberg, and Grilley-Olson; Messrs Moore and Jo; and Ms Eeva); the Department of Medicine, UNC School of Medicine, Chapel Hill, North Carolina (Drs Hayes and Grilley-Olson); the Department of Computer Sciences, University of Wisconsin, Madison (Mr Funkhouser III); the Department of Biostatistics, UNC School of Public Health, Chapel Hill, North Carolina (Dr Fine); Medical Affairs, Ventana Medical Systems, Tucson, Arizona (Dr Banks); Unit of Pathology, Scientific Institute for Research and Health Care, San Giovanni Rotondo, Italy (Dr Graziano); the Department of Pathology, VA Medical Center, Durham, North Carolina (Dr Boswell); the Department of Medical Biosciences, Pathology, Umeå University Hospital, Umeå, Sweden (Dr Elmberger); the Department of Pathology, Kaiser-Permanente Hospital, Santa Clara, California (Dr Raparia); the Department of Pathology, Piedmont Medical Center, Rock Hill, South Carolina (Dr Hart); the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Dr Sholl); the Department of Pathology, Suburban Hospital, Bethesda, Maryland (Dr Nolan); the Department of Pathology, Mayo Clinic, Rochester, Minnesota (Dr Fritchie); the Department of Pathology, VA Medical Center, Dayton, Ohio (Dr Pouagare); the Department of Pathology, University of Texas Medical Branch, Galveston (Dr Allen); the Department of Pathology, Rex Hospital, Raleigh, North Carolina (Dr Volmar); the Department of Pathology, Medical College of Georgia, Augusta (Drs Biddinger and Kleven); the Department of Pathology, Flagstaff Medical Center, Flagstaff, Arizona (Dr Papez); the Department of Pathology, VA Medical Center, Charleston, South Carolina (Dr Spencer); the Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York (Dr Rekhtman); the Department of Pathology, Massachusetts General Hospital, Boston (Drs Mino-Kenudson and Hariri); and the Department of Pathology & Genomic Medicine, Houston Methodist Hospital, Houston, Texas (Drs Driver and Cagle). Dr Allen is currently located at the Department of Pathology at University of Mississippi Medical Center, Jackson.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2017-0481-OADOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556986PMC
December 2018

An Acquired NRAS Q61K Mutation in BRAF V600E-Mutant Lung Adenocarcinoma Resistant to Dabrafenib Plus Trametinib.

J Thorac Oncol 2018 08 6;13(8):e131-e133. Epub 2018 Apr 6.

Lowe Center for Thoracic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.03.026DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102421PMC
August 2018

Sarcoid-Like Granulomatosis of the Lung Related to Immune-Checkpoint Inhibitors: Distinct Clinical and Imaging Features of a Unique Immune-Related Adverse Event.

Cancer Immunol Res 2018 06 5;6(6):630-635. Epub 2018 Apr 5.

Departments of Medical Oncology and Medicine, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://cancerimmunolres.aacrjournals.org/lookup/doi/10.1158/
Publisher Site
http://dx.doi.org/10.1158/2326-6066.CIR-17-0715DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984707PMC
June 2018

Cytologic-histologic correlation of programmed death-ligand 1 immunohistochemistry in lung carcinomas.

Cancer Cytopathol 2018 04 5;126(4):253-263. Epub 2018 Feb 5.

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncy.21973DOI Listing
April 2018

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology.

Arch Pathol Lab Med 2018 Mar 22;142(3):321-346. Epub 2018 Jan 22.

From the Departments of Pathology (Drs Lindeman and Sholl) and Medicine (Dr Kwiatkowski), Brigham and Women's Hospital, Boston, Massachusetts; the Cancer Center (Dr Bernicker) and the Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas (Dr Cagle); the Department of Pathology, University of Colorado School of Medicine, Denver (Dr Aisner); the Diagnostic and Molecular Pathology Laboratory (Dr Arcila) and the Molecular Diagnostics Service (Dr Ladanyi), Memorial Sloan Kettering Cancer Center, New York, New York; the Department of Pathology & Medicine, Pulmonary, Critical Care and Sleep Medicine, New York, New York (Dr Beasley); the Pathology and Laboratory Quality Center, College of American Pathologists, Northfield, Illinois (Mss Colasacco and Ventura); the Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania (Dr Dacic); the Department of Medicine and Pathology, University of Colorado, Denver (Dr Hirsch); the Department of Pathology, University of Aberdeen, Aberdeen, Scotland (Dr Kerr); the Department of Molecular Pathology, Roswell Park Cancer Institute, Buffalo, New York (Dr Nowak); the Clinical and Scientific Affairs Division, Association for Molecular Pathology, Bethesda, Maryland (Dr Temple-Smolkin); the Molecular Therapeutics and Biomarkers Laboratory, Peter Maccallum Cancer Center, Melbourne, Australia (Dr Solomon); the Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands (Dr Thunnissen); the Department of Laboratory Medicine and Pathobiology, Princess Margaret Cancer Center, Toronto, Ontario, Canada (Dr Tsao); Scientific Affairs, International Association for the Study of Lung Cancer, Aurora, Colorado (Dr Wynes); and the Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan (Dr Yatabe). Dr Souter is in private practice in Wellanport, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2017-0388-CPDOI Listing
March 2018

Implications of the tumor immune microenvironment for staging and therapeutics.

Mod Pathol 2018 02 1;31(2):214-234. Epub 2017 Dec 1.

Department of Pathology, The Johns Hopkins University SOM and Bloomberg-Kimmel Institute for Immunotherapy, Baltimore, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2017.156DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132263PMC
February 2018

Molecular diagnostics of lung cancer in the clinic.

Authors:
Lynette Sholl

Transl Lung Cancer Res 2017 Oct;6(5):560-569

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tlcr.2017.08.03DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5653520PMC
October 2017

Next-Generation Sequencing from Liquid Biopsies in Lung Cancer Patients: Advances in Comprehensive Biomarker Testing.

Authors:
Lynette M Sholl

J Thorac Oncol 2017 10;12(10):1464-1466

Brigham and Women's Hospital and Department of Pathology, Harvard Medical School, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.08.004DOI Listing
October 2017

Diffuse Staining for Activated NOTCH1 Correlates With NOTCH1 Mutation Status and Is Associated With Worse Outcome in Adenoid Cystic Carcinoma.

Am J Surg Pathol 2017 Nov;41(11):1473-1482

*Department of Pathology, Massachusetts General Hospital ¶Department of Surgery, Massachusetts General Hospital ‡Department of Pathology, Brigham and Women's Hospital §Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School ∥Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA #Department of Laboratory Medicine & Pathology, Mayo Clinic, Rochester, MN †Northern Institute for Cancer Research, University of Newcastle, Newcastle on Tyne, UK.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00000478-201711000-0000
Publisher Site
http://dx.doi.org/10.1097/PAS.0000000000000945DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5657508PMC
November 2017

Thoracic Complications of Precision Cancer Therapies: A Practical Guide for Radiologists in the New Era of Cancer Care.

Radiographics 2017 Sep-Oct;37(5):1371-1387

From the Departments of Radiology (M.N., H.H., N.H.R.) and Pathology (L.M.S.), Brigham and Women's Hospital and Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/rg.2017170015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5621730PMC
December 2017

GNAS mutations in primary mucinous and non-mucinous lung adenocarcinomas.

Mod Pathol 2017 12 4;30(12):1720-1727. Epub 2017 Aug 4.

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2017.88DOI Listing
December 2017

Next-generation sequencing of cytologic preparations: An analysis of quality metrics.

Cancer Cytopathol 2017 Oct 20;125(10):786-794. Epub 2017 Jul 20.

Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncy.21897DOI Listing
October 2017

Immunohistochemistry of Pulmonary Biomarkers: A Perspective From Members of the Pulmonary Pathology Society.

Arch Pathol Lab Med 2018 Mar 7;142(3):408-419. Epub 2017 Jul 7.

From the Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands (Drs Thunnissen and Radonic); the Department of Pathology, The University of Texas Medical Branch, Galveston (Dr Allen); the Department of Pathology, Gustave Roussy, Villejuif, France (Dr Adam); the Department of Pathology, University of Colorado, Aurora (Dr Aisner); the Department of Pathology, Mount Sinai Medical Center, New York, New York (Dr Beasley); the Department of Pathology, Weill Cornell University Medical Center, New York, New York (Dr Borczuk); the Department of Pathology & Genomic Medicine, Houston Methodist Hospital, Houston, Texas (Drs Cagle and Miller); the Department of Pathology, University of São Paulo, São Paulo, Brazil (Dr Capelozzi); the Department of Pathology, Royal Prince Alfred Hospital, Sydney, Australia (Dr Cooper); the Department of Pathology, Massachusetts General Hospital, Boston (Drs Hariri and Mino-Kenudson); the Department of Pathology, University Clinic Golnik, Golnik, Slovenia (Dr Kern); the Department of Pathology, INSERM U578, CHU A Michallon, Centre Léon Bérard, Lyon, Université Joseph Fourier INSERM U 823, Institut A. Bonniot, Grenoble, France (Dr Lantuejoul); the Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois (Dr Raparia); the Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (Dr Rekhtman); the Department of Pathology, The University Of Texas MD Anderson Cancer Center, Houston (Dr Roy-Chowdhuri); the Department of Pathology, St. Vincent's Pathology, Fitzroy, Australia (Ms Russell); the Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania (Dr Schneider); the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Drs Sholl and Vivero); the Department of Pathology, University of Toronto, University Health Network, Toronto, Ontario, Canada (Dr Tsao); and the Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan (Dr Yatabe).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2017-0106-SADOI Listing
March 2018

Pulmonary Clinicopathological Correlation after Allogeneic Hematopoietic Stem Cell Transplantation: An Autopsy Series.

Biol Blood Marrow Transplant 2017 Oct 28;23(10):1767-1772. Epub 2017 Jun 28.

Department of Medicine, Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2017.06.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5797990PMC
October 2017

Hypersensitivity Pneumonitis A Perspective From Members of the Pulmonary Pathology Society.

Arch Pathol Lab Med 2018 Jan 14;142(1):120-126. Epub 2017 Jun 14.

From the Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas (Drs Miller, Barrios, Cagle, and Ge); the Department of Pathology, University of Texas Medical Branch, Galveston (Dr Allen); the Department of Pathology, Mount Sinai Medical Center, New York, New York (Dr Beasley); the Department of Histopathology, Cork University Hospital, Cork, Ireland (Dr Burke); the Department of Pathology, University of São Paulo, São Paulo, Brazil (Dr Capelozzi); the Department of Pathology, Massachusetts General Hospital, Boston (Drs Hariri, Mark, and Mino-Kenudson); the Department of Pathology, Aberdeen University School of Medicine, Aberdeen, United Kingdom (Dr Kerr); the Department of Laboratory Medicine and Pathology, Mayo Clinic, Jacksonville, Florida (Dr Khoor); the Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, Arizona (Drs Larsen and Smith); the Department of Pathology, National Defense Medical College, Tokorozawa, Japan (Dr Matsubara); the Department of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee (Dr Mehrad); the Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois (Dr Raparia); the Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota (Dr Roden); the Department of Pathology, St Vincent's Pathology, Fitzroy, Australia (Dr Russell); the Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania (Dr Schneider); and the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Dr Sholl).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2017-0138-SADOI Listing
January 2018